Visalytics
Visalytics
approved EB-2 (NIW)

Senior Research Fellow

Biomedical Engineering · India · 2025-09-04

Processing Time
48 days
Decision Date
2025-09-04
Location
Florida
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop precision oncology tools by integrating nanotechnology, immunology, and computational methods to engineer next-generation cancer therapies. His work specifically focuses on designing personalized, neoantigen-based nano vaccines and SMART-lipid nanoparticles to improve immune system responsiveness and overcome tumor immune evasion.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor was found to have national importance due to its potential to transform cancer treatment and support U.S. healthcare innovation.

2 Well-positioned to Advance the Endeavor Met

The petitioner's extensive publication record, high citation count, and Ph.D. credentials demonstrate he is well-positioned to succeed.

3 Balance of Interests/Waiver Benefit Met

USCIS concluded that the petitioner's contributions to precision oncology justify waiving the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in chemical sciences and a strong publication record of 35 peer-reviewed journal articles, 2 abstracts, and 3 book chapters. His work garnered over 500 citations and he completed 26 peer-review invitations, satisfying all three prongs of the Dhanasar framework. Additionally, his research received significant funding from the NIH and the Florida Department of Health.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Judging Experience
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 309 days 2025-04-01
The petitioner proposes to continue research in the United States focused on synthesizing tumor-targeted nanocarriers for RNA therapeutic delivery and improving mRNA purification systems. This work aims to develop cost-effective and scalable solutions for cancer vaccines and RNA-based therapies. The endeavor is designed to address critical challenges in cancer therapy and vaccine manufacturing.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
162 days 2025-04-17
The petitioner proposes to continue his research in molecular biomedicine, specifically focusing on the development of nanoparticle-based delivery systems. His work aims to improve targeted cancer therapies, including chemotherapy, immunotherapy, and tumor thermal therapy, to enhance therapeutic efficacy while reducing side effects. The intended impact is to advance cancer care and oncology breakthroughs within the U.S. healthcare system.
View Case

Consultant

Biotechnology · Turkey

WeGreened EB-2 (NIW) approved
2 days 2023-08-24
The petitioner proposes to continue research on developing cutting-edge nanotherapeutic and nanotheranostic systems, as well as toxicology assays. This work focuses on improving cancer diagnosis and treatment while evaluating and reducing the toxicity of biomedical materials and devices.
View Case

Postdoctoral Researcher

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Ohio 112 days 2023-02-07
The petitioner proposes to continue research on utilizing biomedical engineering in cancer research and development to improve health outcomes for patients. The work focuses on nanotechnology for drug delivery, the exploration of circulating tumor cells (CTCs), and the creation of microfluidic models to inform metastasis research.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-04.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 48 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist